{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T10:22:20Z","timestamp":1778494940039,"version":"3.51.4"},"reference-count":43,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jgisurgery.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Gastrointestinal Surgery"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1007\/s11605-018-3682-4","type":"journal-article","created":{"date-parts":[[2018,1,19]],"date-time":"2018-01-19T15:18:22Z","timestamp":1516375102000},"page":"477-485","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["The Limitations of Standard Clinicopathologic Features to Accurately Risk-Stratify Prognosis after Resection of Intrahepatic Cholangiocarcinoma"],"prefix":"10.1016","volume":"22","author":[{"given":"Fabio","family":"Bagante","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katiuscha","family":"Merath","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Malcolm H.","family":"Squires","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew","family":"Weiss","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sorin","family":"Alexandrescu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hugo P.","family":"Marques","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luca","family":"Aldrighetti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shishir K.","family":"Maithel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlo","family":"Pulitano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Todd W.","family":"Bauer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Feng","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George A.","family":"Poultsides","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olivier","family":"Soubrane","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guillaume","family":"Martel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Groot Koerkamp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alfredo","family":"Guglielmi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Endo","family":"Itaru","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Timothy M.","family":"Pawlik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1007\/s11605-018-3682-4_bb0010","unstructured":"Liver Cancer Study Group of Japan: Intrahepatic cholangiocarcinoma mt, in Okamoto E (ed): Classification of Primary Liver Cancer. Tokyo, Japan, Kanehara, 1997, pp 6\u20137."},{"issue":"4","key":"10.1007\/s11605-018-3682-4_bb0015","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/j.jamcollsurg.2013.05.021","article-title":"Intrahepatic cholangiocarcinoma: management options and emerging therapies","volume":"217","author":"Dodson","year":"2013","journal-title":"J Am Coll Surg."},{"key":"10.1007\/s11605-018-3682-4_bb0020","doi-asserted-by":"crossref","unstructured":"Bagante F, Spolverato G, Weiss M, Alexandrescu S, Marques HP, Aldrighetti L et al. Defining Long-Term Survivors Following Resection of Intrahepatic Cholangiocarcinoma. J Gastrointest Surg. 2017. doi:https:\/\/doi.org\/10.1007\/s11605-017-3550-7.","DOI":"10.1007\/s11605-017-3550-7"},{"issue":"1","key":"10.1007\/s11605-018-3682-4_bb0025","doi-asserted-by":"crossref","first-page":"35","DOI":"10.21037\/hbsn.2016.10.02","article-title":"Staging of intrahepatic cholangiocarcinoma","volume":"6","author":"Ronnekleiv-Kelly","year":"2017","journal-title":"Hepatobiliary Surg Nutr"},{"issue":"9935","key":"10.1007\/s11605-018-3682-4_bb0030","doi-asserted-by":"crossref","first-page":"2168","DOI":"10.1016\/S0140-6736(13)61903-0","volume":"383","author":"Razumilava","year":"2014","journal-title":"Cholangiocarcinoma. Lancet."},{"key":"10.1007\/s11605-018-3682-4_bb0035","doi-asserted-by":"crossref","unstructured":"Bagante F, Spolverato G, Weiss M, Alexandrescu S, Marques HP, Aldrighetti L et al. Assessment of the Lymph Node Status in Patients Undergoing Liver Resection for Intrahepatic Cholangiocarcinoma: the New Eighth Edition AJCC Staging System. J Gastrointest Surg. 2017. doi:https:\/\/doi.org\/10.1007\/s11605-017-3426-x.","DOI":"10.1007\/s11605-017-3426-x"},{"key":"10.1007\/s11605-018-3682-4_bb0040","doi-asserted-by":"crossref","unstructured":"Spolverato G, Bagante F, Weiss M, Alexandrescu S, Marques HP, Aldrighetti L et al. Comparative performances of the 7th and the 8th editions of the American Joint Committee on Cancer staging systems for intrahepatic cholangiocarcinoma. J Surg Oncol. 2017. doi:https:\/\/doi.org\/10.1002\/jso.24569.","DOI":"10.1002\/jso.24569"},{"issue":"9","key":"10.1007\/s11605-018-3682-4_bb0045","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1200\/JCO.2012.41.5984","article-title":"Prognostic nomogram for intrahepatic cholangiocarcinoma after partial hepatectomy","volume":"31","author":"Wang","year":"2013","journal-title":"J Clin Oncol."},{"issue":"5","key":"10.1007\/s11605-018-3682-4_bb0050","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1001\/jamasurg.2013.5168","article-title":"A nomogram to predict long-term survival after resection for intrahepatic cholangiocarcinoma: an Eastern and Western experience","volume":"149","author":"Hyder","year":"2014","journal-title":"JAMA Surg."},{"issue":"1","key":"10.1007\/s11605-018-3682-4_bb0055","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1002\/cncr.29686","article-title":"Proposal of a new staging system for intrahepatic cholangiocarcinoma: Analysis of surgical patients from a nationwide survey of the Liver Cancer Study Group of Japan","volume":"122","author":"Sakamoto","year":"2016","journal-title":"Cancer."},{"issue":"7","key":"10.1007\/s11605-018-3682-4_bb0060","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1002\/jhbp.92","article-title":"Proposal of a new staging system for mass-forming intrahepatic cholangiocarcinoma: a multicenter analysis by the Study Group for Hepatic Surgery of the Japanese Society of Hepato-Biliary-Pancreatic Surgery","volume":"21","author":"Uenishi","year":"2014","journal-title":"J Hepatobiliary Pancreat Sci."},{"issue":"9","key":"10.1007\/s11605-018-3682-4_bb0065","doi-asserted-by":"crossref","first-page":"2374","DOI":"10.1002\/1097-0142(20011101)92:9<2374::AID-CNCR1585>3.0.CO;2-L","article-title":"A new staging system for mass-forming intrahepatic cholangiocarcinoma: analysis of preoperative and postoperative variables","volume":"92","author":"Okabayashi","year":"2001","journal-title":"Cancer."},{"issue":"1","key":"10.1007\/s11605-018-3682-4_bb0070","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1245\/s10434-008-0180-z","article-title":"A proposed staging system for intrahepatic cholangiocarcinoma","volume":"16","author":"Nathan","year":"2009","journal-title":"Ann Surg Oncol."},{"key":"10.1007\/s11605-018-3682-4_bb0075","doi-asserted-by":"crossref","unstructured":"Buettner S, Galjart B, van Vugt JLA, Bagante F, Alexandrescu S, Marques HP et al. Performance of prognostic scores and staging systems in predicting long-term survival outcomes after surgery for intrahepatic cholangiocarcinoma. J Surg Oncol. 2017. doi:https:\/\/doi.org\/10.1002\/jso.24759.","DOI":"10.1002\/jso.24759"},{"issue":"1","key":"10.1007\/s11605-018-3682-4_bb0080","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1186\/s12885-017-3464-5","article-title":"Risk stratification system to predict recurrence of intrahepatic cholangiocarcinoma after hepatic resection","volume":"17","author":"Jeong","year":"2017","journal-title":"BMC Cancer."},{"key":"10.1007\/s11605-018-3682-4_bb0085","unstructured":"Amin MB EiC, American Joint Committee on Cancer. Springer. 2017."},{"issue":"34","key":"10.1007\/s11605-018-3682-4_bb0090","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta10340","article-title":"Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy","volume":"10","author":"Williams","year":"2006","journal-title":"Health Technol Assess."},{"issue":"6","key":"10.1007\/s11605-018-3682-4_bb0095","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1245\/s10434-010-0985-4","article-title":"The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM","volume":"17","author":"Edge","year":"2010","journal-title":"Ann Surg Oncol."},{"issue":"2","key":"10.1007\/s11605-018-3682-4_bb0100","first-page":"93","article-title":"The Eighth Edition AJCC Cancer Staging Manual: Continuing to build a bridge from a population-based to a more \"personalized\" approach to cancer staging","volume":"67","author":"Amin","year":"2017","journal-title":"CA Cancer J Clin."},{"issue":"1","key":"10.1007\/s11605-018-3682-4_bb0105","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/cncr.11898","article-title":"The process for continuous improvement of the TNM classification","volume":"100","author":"Gospodarowicz","year":"2004","journal-title":"Cancer."},{"key":"10.1007\/s11605-018-3682-4_bb0110","doi-asserted-by":"crossref","unstructured":"Mahar AL, Compton C, Halabi S, Hess KR, Weiser MR, Groome PA. Personalizing prognosis in colorectal cancer: A systematic review of the quality and nature of clinical prognostic tools for survival outcomes. J Surg Oncol. 2017. doi:https:\/\/doi.org\/10.1002\/jso.24774.","DOI":"10.1002\/jso.24774"},{"issue":"11","key":"10.1007\/s11605-018-3682-4_bb0115","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1097\/JTO.0000000000000652","article-title":"Refining Prognosis in Lung Cancer: A Report on the Quality and Relevance of Clinical Prognostic Tools","volume":"10","author":"Mahar","year":"2015","journal-title":"J Thorac Oncol."},{"issue":"9","key":"10.1007\/s11605-018-3682-4_bb0120","doi-asserted-by":"crossref","first-page":"2753","DOI":"10.1245\/s10434-016-5212-5","article-title":"Critical Assessment of Clinical Prognostic Tools in Melanoma","volume":"23","author":"Mahar","year":"2016","journal-title":"Ann Surg Oncol."},{"issue":"3","key":"10.1007\/s11605-018-3682-4_bb0125","doi-asserted-by":"crossref","first-page":"204","DOI":"10.5230\/jgc.2017.17.e21","article-title":"External Validation of a Gastric Cancer Nomogram Derived from a Large-volume Center Using Dataset from a Medium-volume Center","volume":"17","author":"Kim","year":"2017","journal-title":"J Gastric Cancer."},{"issue":"6","key":"10.1007\/s11605-018-3682-4_bb0130","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1001\/jamasurg.2013.5137","article-title":"Treatment and Prognosis for Patients With Intrahepatic Cholangiocarcinoma: Systematic Review and Meta-analysis","volume":"149","author":"Mavros","year":"2014","journal-title":"JAMA Surg."},{"issue":"5","key":"10.1007\/s11605-018-3682-4_bb0135","doi-asserted-by":"crossref","first-page":"e170117","DOI":"10.1001\/jamasurg.2017.0117","article-title":"Development and Validation of a Prognostic Score for Intrahepatic Cholangiocarcinoma","volume":"152","author":"Raoof","year":"2017","journal-title":"JAMA Surg."},{"issue":"13","key":"10.1007\/s11605-018-3682-4_bb0140","doi-asserted-by":"crossref","first-page":"2878","DOI":"10.1016\/j.celrep.2017.06.008","article-title":"Integrative Genomic Analysis of Cholangiocarcinoma Identifies Distinct IDH-Mutant Molecular Profiles","volume":"19","author":"Farshidfar","year":"2017","journal-title":"Cell Rep."},{"issue":"12","key":"10.1007\/s11605-018-3682-4_bb0145","doi-asserted-by":"crossref","first-page":"3827","DOI":"10.1245\/s10434-014-3828-x","article-title":"Genomic profiling of intrahepatic cholangiocarcinoma: refining prognosis and identifying therapeutic targets","volume":"21","author":"Zhu","year":"2014","journal-title":"Ann Surg Oncol."},{"issue":"10","key":"10.1007\/s11605-018-3682-4_bb0150","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1158\/2159-8290.CD-17-0368","article-title":"Whole-Genome and Epigenomic Landscapes of Etiologically Distinct Subtypes of Cholangiocarcinoma","volume":"7","author":"Jusakul","year":"2017","journal-title":"Cancer Discov."},{"issue":"6","key":"10.1007\/s11605-018-3682-4_bb0155","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1038\/nrclinonc.2016.65","article-title":"The future of cancer treatment: immunomodulation, CARs and combination immunotherapy","volume":"13","author":"Khalil","year":"2016","journal-title":"Nat Rev Clin Oncol."},{"issue":"3","key":"10.1007\/s11605-018-3682-4_bb0160","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1111\/his.13238","article-title":"PD-L1 expression in extrahepatic cholangiocarcinoma","volume":"71","author":"Walter","year":"2017","journal-title":"Histopathology."},{"issue":"3","key":"10.1007\/s11605-018-3682-4_bb0165","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.jhep.2017.03.026","article-title":"Emerging molecular therapeutic targets for cholangiocarcinoma","volume":"67","author":"Rizvi","year":"2017","journal-title":"J Hepatol."},{"key":"10.1007\/s11605-018-3682-4_bb0170","doi-asserted-by":"crossref","unstructured":"Aravalli RN, Steer CJ. Immune-Mediated Therapies for Liver Cancer. Genes (Basel). 2017;8(2). doi:https:\/\/doi.org\/10.3390\/genes8020076.","DOI":"10.3390\/genes8020076"},{"key":"10.1007\/s11605-018-3682-4_bb0175","doi-asserted-by":"crossref","unstructured":"Rizvi S, Khan SA, Hallemeier CL, Kelley RK, Gores GJ. Cholangiocarcinoma\u2014evolving concepts and therapeutic strategies. Nat Rev Clin Oncol. 2017. doi:https:\/\/doi.org\/10.1038\/nrclinonc.2017.157.","DOI":"10.1038\/nrclinonc.2017.157"},{"key":"10.1007\/s11605-018-3682-4_bb0180","doi-asserted-by":"crossref","unstructured":"Fontugne J, Augustin J, Pujals A, Compagnon P, Rousseau B, Luciani A et al. PD-L1 expression in perihilar and intrahepatic cholangiocarcinoma. Oncotarget. 2017;8(15):24644\u201351. doi:https:\/\/doi.org\/10.18632\/oncotarget.15602.","DOI":"10.18632\/oncotarget.15602"},{"key":"10.1007\/s11605-018-3682-4_bb0185","doi-asserted-by":"crossref","first-page":"33789","DOI":"10.1038\/srep33789","article-title":"Prognostic Significance of Neutrophil to Lymphocyte Ratio in Oncologic Outcomes of Cholangiocarcinoma: A Meta-analysis","volume":"6","author":"Tan","year":"2016","journal-title":"Sci Rep."},{"issue":"1","key":"10.1007\/s11605-018-3682-4_bb0190","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1038\/s41598-017-01652-0","article-title":"Assessment of neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio and platelet count as predictors of long-term outcome after R0 resection for colorectal cancer","volume":"7","author":"Pedrazzani","year":"2017","journal-title":"Sci Rep."},{"issue":"2","key":"10.1007\/s11605-018-3682-4_bb0195","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1097\/SLA.0000000000001988","article-title":"Neutrophil-to-lymphocyte Ratio is a Predictive Marker for Invasive Malignancy in Intraductal Papillary Mucinous Neoplasms of the Pancreas","volume":"266","author":"Gemenetzis","year":"2017","journal-title":"Ann Surg."},{"issue":"2","key":"10.1007\/s11605-018-3682-4_bb0200","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.suronc.2017.03.001","article-title":"Multidisciplinary management of intrahepatic cholangiocarcinoma: Current approaches","volume":"26","author":"Guro","year":"2017","journal-title":"Surg Oncol."},{"issue":"4_suppl","key":"10.1007\/s11605-018-3682-4_bb0205","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1200\/JCO.2017.35.4_suppl.225","article-title":"Gemox versus surveillance following surgery of localized biliary tract cancer: Results of the PRODIGE 12-ACCORD 18 (UNICANCER GI) phase III trial","volume":"35","author":"Edeline","year":"2017","journal-title":"Journal of Clinical Oncology"},{"issue":"15_suppl","key":"10.1007\/s11605-018-3682-4_bb0210","doi-asserted-by":"crossref","first-page":"4006","DOI":"10.1200\/JCO.2017.35.15_suppl.4006","article-title":"Adjuvant capecitabine for biliary tract cancer: The BILCAP randomized study","volume":"35","author":"Primrose","year":"2017","journal-title":"Journal of Clinical Oncology"},{"issue":"10","key":"10.1007\/s11605-018-3682-4_bb0215","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/j.hpb.2017.06.008","article-title":"Impact of adjuvant chemotherapy on survival in patients with intrahepatic cholangiocarcinoma: a multi-institutional analysis","volume":"19","author":"Reames","year":"2017","journal-title":"HPB (Oxford)."},{"issue":"5","key":"10.1007\/s11605-018-3682-4_bb0220","doi-asserted-by":"crossref","first-page":"563","DOI":"10.6004\/jnccn.2017.0059","article-title":"NCCN Guidelines Insights: Hepatobiliary Cancers, Version 1.2017","volume":"15","author":"Benson","year":"2017","journal-title":"J Natl Compr Canc Netw."}],"container-title":["Journal of Gastrointestinal Surgery"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11605-018-3682-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11605-018-3682-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1091255X23033152?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1091255X23033152?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11605-018-3682-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T19:54:02Z","timestamp":1761076442000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1091255X23033152"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3]]},"references-count":43,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,3]]}},"alternative-id":["S1091255X23033152"],"URL":"https:\/\/doi.org\/10.1007\/s11605-018-3682-4","relation":{},"ISSN":["1091-255X"],"issn-type":[{"value":"1091-255X","type":"print"}],"subject":[],"published":{"date-parts":[[2018,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Limitations of Standard Clinicopathologic Features to Accurately Risk-Stratify Prognosis after Resection of Intrahepatic Cholangiocarcinoma","name":"articletitle","label":"Article Title"},{"value":"Journal of Gastrointestinal Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1007\/s11605-018-3682-4","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2018 Society for Surgery of the Alimentary Tract. Published by ELSEVIER INC. All rights reserved. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}